Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement

•Risk of renarrowing often drives selection of drug eluting vs. bare metal stent.•However, relative importance of angiographic data vs. clinical data remains unclear.•In a large PCI registry, we found 4.5% rate of target lesion revascularization.•Angiographic characteristics improved risk assessment by >20% over clinical data.•Thus, stent selection may be best performed after coronary anatomy is known.